| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Total liabilities and stockholders' equity | $1.7T | $1.7T | $1.7T | $1.8T | $1.8T | $1.8T | $1.8T | $2.1T |
| Retained earnings | $148.7B | $150.5B | $153.4B | $157.0B | $159.5B | $162.1B | $165.3B | $169.3B |
| Treasury Stock, Value | $105.5B | $106.5B | $108.5B | $112.8B | $115.9B | $117.9B | $120.9B | $125.9B |
| Total stockholders' equity | $119.5B | $121.2B | $122.0B | $124.3B | $124.1B | $124.4B | $125.0B | $122.8B |
| Additional paid-in capital | $61.4B | $61.4B | $61.4B | $61.8B | $61.9B | $61.9B | $61.9B | $61.8B |
| Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding | $12.8B | $13.3B | $13.3B | $15.2B | $15.2B | $15.2B | $15.2B | $13.7B |
| Share-based awards | $5.1B | $5.1B | $5.1B | $5.2B | $5.4B | $5.6B | $5.8B | $5.8B |
| Accumulated other comprehensive income (loss) | -$2.9B | -$2.5B | -$2.7B | -$2.1B | -$2.0B | -$2.5B | -$2.3B | -$1.9B |
| Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | $9.0M | $9.0M | $9.0M | $9.0M | $9.0M | $9.0M | $9.0M | $9.0M |
| Nonvoting common stock; no shares issued and outstanding | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |